
Bioorganic Chemistry (2019)
Update date:2022-08-04
Topics:
Mohammed, Hamada H.H.
Abdelhafez, El-Shimaa M.N.
Abbas, Samar H.
Moustafa, Gamal A.I.
Hauk, Glenn
Berger, James M.
Mitarai, Satoshi
Arai, Masayoshi
Abd El-Baky, Rehab M.
Abuo-Rahma, Gamal El-Din A.
New N-4-piperazinyl ciprofloxacin-triazole hybrids 6a-o were prepared and characterized. The in vitro antimycobacterial activity revealed that compound 6a experienced promising antimycobacterial activity against Mycobactrium smegmatis compared with the reference isoniazide (INH). Additionally, compound 6a exhibited broad spectrum antibacterial activity against all the tested strains either Gram-positive or Gram-negative bacteria compared with the reference ciprofloxacin. Also, compounds 6g and 6i displayed considerable antifungal activity compared with the reference ketoconazole. DNA cleavage assay of the highly active compounds 6c and 6h showed a good correlation between the Mycobactrium cleaved DNA gyrase assay and their in vitro antimycobactrial activity. Moreover, molecular modeling studies were done for the designed ciprofloxacin derivatives to predict their binding modes towards Topoisomerase II enzyme (PDB: 5bs8).
View MoreShuanghe Bio-Technology Limited(expird)
Contact:+86-571-61710758,18968016640
Address:Jinqiao north road 916# Fuyang
website:http://www.np-chem.com
Contact:0086-25-52346877
Address:199, Jian Ye Road, Nanjing, China
Contact:0571-
Address:zhejing
website:http://www.chinabarton.com
Contact:+86-573-82719618
Address:No. 162 Fumin Road, Honghe Town,
GUANGZHOU MEDCAN PHARMATECH LTD
website:http://www.gzmedcan.com
Contact:+86-20-82519649
Address:Building J,Room 101,1 JiangtashanRd,Guang Zhou Science City,Guang Zhou ,China
Doi:10.1016/j.tetlet.2006.07.026
(2006)Doi:10.1016/j.tet.2016.10.058
(2016)Doi:10.1021/ol061461d
(2006)Doi:10.1055/s-2002-32964
(2002)Doi:10.1007/BF00909415
()Doi:10.1021/acs.joc.8b02866
(2019)